Knowledge Distillery

From a sample of 208 consecutive non-neurological patients hospitalised for COVID-19 disease, 165 survivors were re-assessed at 6 months according to…

In this nice editorial, Prof. Johann Sellner discusses the possible role of translational neuroscience research in the current COVID-19 outbreak.

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

In this article the authors aimed to investigate the frequency and clinical associations of COVID-19 vaccine-related headache.

The current COVID-19 outbreak, caused by the novel SARS-CoV-2, has raised the possibility of potential neurotropic properties of this virus.

Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks

This study quantifies changes in neuro-oncological care during the height of the pandemic and investigates patient outcomes in 2020 compared to a…

The aim of this randomised, double-blind, placebo-controlled, multicentre trial was to analyze the effects of Remdesivir in adult patients with severe…

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

This study aimed to describe gross and microscopic CNS pathology findings from the autopsies and correlate them with the clinical and laboratory…

The objective of this parallel, double-masked, randomized, phase IIb clinical trial, was to evaluate the safety and efficacy of 2 chloroquine…

Reduction in mobility and COVID-19 transmission